B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors.
B7 homologue 3
Colorectal cancer
Esophageal cancer
Gastric cancer
Gastrointestinal tumors
Targeted therapy
Journal
World journal of gastrointestinal oncology
ISSN: 1948-5204
Titre abrégé: World J Gastrointest Oncol
Pays: China
ID NLM: 101532470
Informations de publication
Date de publication:
15 Aug 2021
15 Aug 2021
Historique:
received:
20
02
2021
revised:
19
04
2021
accepted:
07
07
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
ppublish
Résumé
The most common digestive system (DS) cancers, including tumors of the gastrointestinal tract (GIT) such as colorectal cancer (CRC), gastric cancer (GC) and esophageal cancer (EC) as well as tumors of DS accessory organs such as pancreatic and liver cancer, are responsible for more than one-third of all cancer-related deaths worldwide, despite the progress that has been achieved in anticancer therapy. Due to these limitations in treatment strategies, oncological research has taken outstanding steps towards a better understanding of cancer cell biological complexity and heterogeneity. These studies led to new molecular target-driven therapeutic approaches. Different
Identifiants
pubmed: 34457187
doi: 10.4251/wjgo.v13.i8.799
pmc: PMC8371522
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
799-821Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare no conflicts of interest.
Références
J Clin Oncol. 2009 Sep 10;27(26):4422-32
pubmed: 19667270
Cancer Immunol Res. 2016 Sep 2;4(9):721-5
pubmed: 27590281
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
J Surg Res. 2014 May 15;188(2):396-403
pubmed: 24630518
Front Oncol. 2020 Jan 10;9:1466
pubmed: 31998637
J Biomed Sci. 2019 Oct 20;26(1):78
pubmed: 31629410
Scand J Gastroenterol. 2015 Jun;50(6):657-67
pubmed: 25901896
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Eur J Hum Genet. 2016 Sep;24 Suppl 1:S3-9
pubmed: 27514841
Pak J Med Sci. 2016 Nov-Dec;32(6):1568-1573
pubmed: 28083066
Cancer Med. 2020 Jan;9(1):361-373
pubmed: 31693304
BMC Cancer. 2014 Aug 20;14:602
pubmed: 25139714
Cancers (Basel). 2018 Mar 19;10(3):
pubmed: 29562660
Cancer Sci. 2011 May;102(5):1019-24
pubmed: 21251161
Eur J Surg Oncol. 2018 Aug;44(8):1254-1260
pubmed: 29871819
N Biotechnol. 2011 Sep;28(5):518-29
pubmed: 21473941
World J Gastroenterol. 2019 Oct 14;25(38):5773-5788
pubmed: 31636471
Annu Rev Cell Dev Biol. 2001;17:463-516
pubmed: 11687497
Clin Oncol Res. 2019;2(5):
pubmed: 31998864
Anticancer Agents Med Chem. 2012 Jul;12(6):631-9
pubmed: 22263797
Cancer Med. 2019 Oct;8(13):6114-6126
pubmed: 31448582
Cell Death Dis. 2020 Oct 3;11(10):824
pubmed: 33011740
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Oncogene. 2018 Apr;37(15):1949-1960
pubmed: 29367755
Oncotarget. 2014 Nov 15;5(21):10901-15
pubmed: 25337721
Ann Med Surg (Lond). 2014 Sep 11;3(4):113-6
pubmed: 25568796
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Avicenna J Med Biotechnol. 2019 Jan-Mar;11(1):3-23
pubmed: 30800238
Onco Targets Ther. 2016 Oct 12;9:6257-6263
pubmed: 27785073
Pharmacol Res Perspect. 2019 Dec;7(6):e00535
pubmed: 31859459
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Nat Immunol. 2001 Mar;2(3):269-74
pubmed: 11224528
Oncol Rep. 2016 Jul;36(1):231-8
pubmed: 27175567
Dtsch Arztebl Int. 2019 Feb 22;116(8):119-126
pubmed: 30940340
J Hematol Oncol. 2015 Dec 21;8:130
pubmed: 26692321
Cell Death Dis. 2019 Apr 5;10(4):308
pubmed: 30952834
Crit Rev Eukaryot Gene Expr. 1995;5(2):127-56
pubmed: 8845581
Methods Mol Biol. 2012;921:41-50
pubmed: 23015490
World J Gastroenterol. 2015 Jul 14;21(26):7933-43
pubmed: 26185366
Nat Rev Dis Primers. 2017 Jul 27;3:17048
pubmed: 28748917
Thorac Cancer. 2020 May;11(5):1121-1128
pubmed: 32154652
Cell Mol Immunol. 2020 Jan;17(1):50-63
pubmed: 31804619
Mol Ther Oncolytics. 2020 Apr 07;17:180-189
pubmed: 32346608
Cancer Res. 2006 May 15;66(10):5039-46
pubmed: 16707425
Sci Rep. 2016 Jun 08;6:27528
pubmed: 27273624
Theranostics. 2020 Jun 18;10(17):7622-7634
pubmed: 32685008
Medicina (Kaunas). 2019 Dec 30;56(1):
pubmed: 31906017
BioDrugs. 2011 Dec 1;25(6):365-79
pubmed: 22050339
Acta Oncol. 2020 Apr;59(4):434-437
pubmed: 31920132
Oncotarget. 2016 Nov 22;7(47):77237-77243
pubmed: 27764786
Medicine (Baltimore). 2019 Feb;98(8):e14663
pubmed: 30813210
World J Gastroenterol. 2018 Aug 21;24(31):3538-3546
pubmed: 30131660
Mol Med Rep. 2019 May;19(5):4315-4325
pubmed: 30942404
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
Nat Rev Cancer. 2009 Nov;9(11):798-809
pubmed: 19851315
Gastroenterol Hepatol Bed Bench. 2015 Spring;8(Suppl 1):S6-S14
pubmed: 26171139
Oncogene. 2007 May 14;26(22):3291-310
pubmed: 17496923
Am J Transl Res. 2015 Dec 15;7(12):2646-60
pubmed: 26885263
Gastroenterol Clin North Am. 2016 Sep;45(3):413-28
pubmed: 27546840
Curr Biol. 2009 Nov 3;19(20):1712-7
pubmed: 19818619
Tumour Biol. 2016 Mar;37(3):2961-71
pubmed: 26411671
Adv Exp Med Biol. 2019;1189:25-51
pubmed: 31758530
Trends Cell Biol. 2013 Dec;23(12):620-33
pubmed: 23958396
Front Pharmacol. 2018 Jun 26;9:642
pubmed: 29997500
Cancers (Basel). 2020 Sep 09;12(9):
pubmed: 32916883
Ann Cardiothorac Surg. 2017 Mar;6(2):131-136
pubmed: 28447001
Front Immunol. 2020 May 05;11:681
pubmed: 32477326
Carcinogenesis. 2000 Mar;21(3):379-85
pubmed: 10688858
World J Gastroenterol. 2006 Jan 21;12(3):457-9
pubmed: 16489649
Front Oncol. 2020 Sep 15;10:546110
pubmed: 33042836
Int J Mol Sci. 2017 Jan 19;18(1):
pubmed: 28106826
Front Cell Dev Biol. 2020 Feb 13;8:41
pubmed: 32117972
Drug Des Devel Ther. 2018 Jan 22;12:195-208
pubmed: 29403265
Mol Med Rep. 2015 Oct;12(4):5455-60
pubmed: 26151358
Int J Biol Sci. 2020 Mar 25;16(11):1767-1773
pubmed: 32398947
Oncoimmunology. 2018 Jul 11;7(10):e1488566
pubmed: 30288357
J Oncol. 2019 Sep 19;2019:7407190
pubmed: 31641356
Transl Gastroenterol Hepatol. 2016 Apr 06;1:24
pubmed: 28138591
Oncotarget. 2017 May 13;8(42):71725-71735
pubmed: 29069741
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248
pubmed: 29405201
Clin Oncol (R Coll Radiol). 2014 Sep;26(9):541-50
pubmed: 24996375
Oncotarget. 2015 Feb 20;6(5):3452-61
pubmed: 25609202
Oncol Lett. 2017 Dec;14(6):7185-7190
pubmed: 29344150
Signal Transduct Target Ther. 2020 Oct 7;5(1):229
pubmed: 33028804
J Cancer. 2020 Feb 3;11(8):2158-2170
pubmed: 32127943
Annu Rev Immunol. 2005;23:515-48
pubmed: 15771580
Cell Death Dis. 2020 Jan 23;11(1):55
pubmed: 31974361
Cancer Cell. 2017 Apr 10;31(4):501-515.e8
pubmed: 28399408
Oncoimmunology. 2020 Apr 14;9(1):1748991
pubmed: 32363121
Biomark Res. 2020 Aug 26;8:34
pubmed: 32864131
J Natl Cancer Inst. 2010 Jul 7;102(13):932-41
pubmed: 20513808
Front Immunol. 2020 Sep 18;11:1624
pubmed: 33042104
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
J Neurooncol. 2010 May;97(3):409-18
pubmed: 19890606
Adv Cancer Res. 2014;124:31-82
pubmed: 25287686
Int J Cancer. 2012 Dec 1;131(11):2528-36
pubmed: 22473715
Neoplasia. 2000 Jul-Aug;2(4):291-9
pubmed: 11005563
World J Gastroenterol. 2014 Feb 21;20(7):1635-49
pubmed: 24587643
Genome Biol. 2005;6(6):223
pubmed: 15960813
Trends Pharmacol Sci. 2003 Mar;24(3):139-45
pubmed: 12628359
Sci Rep. 2020 Aug 4;10(1):13160
pubmed: 32753702
Int J Mol Sci. 2020 Jun 04;21(11):
pubmed: 32512697
Cell. 2017 Apr 20;169(3):381-405
pubmed: 28431241
Prz Gastroenterol. 2019;14(1):26-38
pubmed: 30944675
Cancer Immunol Immunother. 2010 Aug;59(8):1163-71
pubmed: 20333377
Biochem Soc Trans. 1997 Feb;25(1):107-12
pubmed: 9056853
Am Fam Physician. 2017 Jan 1;95(1):22-28
pubmed: 28075104
Clin Cancer Res. 2021 Mar 1;27(5):1227-1235
pubmed: 33051306
Cancer Cell. 2019 Feb 11;35(2):221-237.e8
pubmed: 30753824
J Immunol. 2009 Dec 15;183(12):8099-109
pubmed: 20007577
Clin Cancer Res. 2016 Jul 15;22(14):3425-3431
pubmed: 27208063
Lancet. 2020 Aug 29;396(10251):635-648
pubmed: 32861308
Int J Biol Sci. 2020 Jan 1;16(4):568-582
pubmed: 32025206
Mod Pathol. 2020 Nov;33(11):2330-2340
pubmed: 32514163
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20759-63
pubmed: 18077395
Oncotarget. 2017 Sep 21;8(54):93156-93167
pubmed: 29190985
Mol Cell. 2003 Nov;12(5):1087-99
pubmed: 14636569
Clin Cancer Res. 2001 Aug;7(8):2168-81
pubmed: 11489790
World J Clin Oncol. 2020 Oct 24;11(10):761-808
pubmed: 33200074
Cancer Chemother Pharmacol. 2018 Feb;81(2):245-253
pubmed: 29299639
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Oncotarget. 2016 May 17;7(20):29480-91
pubmed: 27121051
J Pathol. 2010 Dec;222(4):350-66
pubmed: 20927778
Curr Pharm Biotechnol. 2018;19(1):5-18
pubmed: 29667553
Transl Oncol. 2020 Feb;13(2):365-371
pubmed: 31887631
Int J Cancer. 2014 Jun 15;134(12):2764-71
pubmed: 24013874
J Clin Invest. 2002 May;109(9):1139-42
pubmed: 11994401
Am J Transl Res. 2019 Jul 15;11(7):4438-4449
pubmed: 31396347
Med Oncol. 2012 Sep;29(3):1716-22
pubmed: 21630055
PLoS One. 2014 Apr 21;9(4):e95517
pubmed: 24751697
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Pharmacol. 2000 Nov;58(5):920-7
pubmed: 11040038
Biochem Biophys Res Commun. 2017 Aug 26;490(3):1132-1138
pubmed: 28676400
Cell Physiol Biochem. 2018;51(1):1-10
pubmed: 30439711
J Cell Sci. 2007 Oct 1;120(Pt 19):3327-35
pubmed: 17881494
Oncotarget. 2016 May 31;7(22):31755-71
pubmed: 27145365
Oncol Rep. 2014 Nov;32(5):2086-92
pubmed: 25120098
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Am J Clin Exp Immunol. 2017 Jun 15;6(4):66-75
pubmed: 28695059
N Engl J Med. 2010 Mar 11;362(10):875-85
pubmed: 20220182
Oncol Lett. 2017 Nov;14(5):6177-6183
pubmed: 29113264
Nat Genet. 2019 Feb;51(2):202-206
pubmed: 30643254
Oncotarget. 2015 May 20;6(14):12574-86
pubmed: 25909291
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
J Biol Chem. 1996 Dec 6;271(49):31704-10
pubmed: 8940193
J Clin Med. 2018 Jul 10;7(7):
pubmed: 29996538
Hepatogastroenterology. 2013 Jun;60(124):704-8
pubmed: 23262265
World J Gastroenterol. 2015 Feb 14;21(6):1804-13
pubmed: 25684945
Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):137-155
pubmed: 29607374